US20180368991A1 - Intervertebral cage for arthrodesis - Google Patents

Intervertebral cage for arthrodesis Download PDF

Info

Publication number
US20180368991A1
US20180368991A1 US15/742,919 US201615742919A US2018368991A1 US 20180368991 A1 US20180368991 A1 US 20180368991A1 US 201615742919 A US201615742919 A US 201615742919A US 2018368991 A1 US2018368991 A1 US 2018368991A1
Authority
US
United States
Prior art keywords
intervertebral cage
titanium material
porous titanium
pores
contact zone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/742,919
Inventor
Jerome Levieux
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Spineart SA
Original Assignee
Spineart SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spineart SA filed Critical Spineart SA
Assigned to SPINEART SA reassignment SPINEART SA ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: LEVIEUX, Jérôme
Publication of US20180368991A1 publication Critical patent/US20180368991A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/4455Joints for the spine, e.g. vertebrae, spinal discs for the fusion of spinal bodies, e.g. intervertebral fusion of adjacent spinal bodies, e.g. fusion cages
    • A61F2/4465Joints for the spine, e.g. vertebrae, spinal discs for the fusion of spinal bodies, e.g. intervertebral fusion of adjacent spinal bodies, e.g. fusion cages having a circular or kidney shaped cross-section substantially perpendicular to the axis of the spine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/44Joints for the spine, e.g. vertebrae, spinal discs
    • A61F2/4455Joints for the spine, e.g. vertebrae, spinal discs for the fusion of spinal bodies, e.g. intervertebral fusion of adjacent spinal bodies, e.g. fusion cages
    • A61F2/447Joints for the spine, e.g. vertebrae, spinal discs for the fusion of spinal bodies, e.g. intervertebral fusion of adjacent spinal bodies, e.g. fusion cages substantially parallelepipedal, e.g. having a rectangular or trapezoidal cross-section
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/28Bones
    • A61F2002/2835Bone graft implants for filling a bony defect or an endoprosthesis cavity, e.g. by synthetic material or biological material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30003Material related properties of the prosthesis or of a coating on the prosthesis
    • A61F2002/30004Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis
    • A61F2002/30011Material related properties of the prosthesis or of a coating on the prosthesis the prosthesis being made from materials having different values of a given property at different locations within the same prosthesis differing in porosity
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2002/30001Additional features of subject-matter classified in A61F2/28, A61F2/30 and subgroups thereof
    • A61F2002/30316The prosthesis having different structural features at different locations within the same prosthesis; Connections between prosthetic parts; Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30535Special structural features of bone or joint prostheses not otherwise provided for
    • A61F2002/30593Special structural features of bone or joint prostheses not otherwise provided for hollow
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/30769Special external or bone-contacting surface, e.g. coating for improving bone ingrowth madreporic
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/30767Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
    • A61F2002/3092Special external or bone-contacting surface, e.g. coating for improving bone ingrowth having an open-celled or open-pored structure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/3094Designing or manufacturing processes
    • A61F2002/30985Designing or manufacturing processes using three dimensional printing [3DP]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61FFILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02Prostheses implantable into the body
    • A61F2/30Joints
    • A61F2/46Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor
    • A61F2/4603Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof
    • A61F2002/4629Special tools or methods for implanting or extracting artificial joints, accessories, bone grafts or substitutes, or particular adaptations therefor for insertion or extraction of endoprosthetic joints or of accessories thereof connected to the endoprosthesis or implant via a threaded connection

Definitions

  • the present invention relates to intervertebral cages for arthrodesis, which are also called “intersomatic cages”.
  • Arthrodesis is a surgical operation in which two bones that are initially movable with respect to each other are fixed. It is performed in order to correct a lesion in a bone region and to eliminate the pain associated with movements of this lesion; it is irreversible. It is also referred to as “fusion”.
  • intervertebral discs In humans, degeneration of the intervertebral disc tends to reduce the space within the disc and to narrow the foramina through which the nerve roots issue from the spinal canal. This degeneration represents one of the diseases of the spine.
  • the intervertebral discs are located in the vertebral column between two consecutive vertebrae.
  • An intervertebral disc comprises a ring of cartilage provided at its center with a gelatinous nucleus. The intervertebral discs are elastic and thus help absorb the shocks to which a vertebral column is subjected.
  • intervertebral disc may necessitate arthrodesis (fusion) of one or more vertebral segments in the best possible anatomical position.
  • arthrodesis fusion
  • This technique thus makes it possible to definitively block one or more of the intervertebral articulations of the column.
  • intervertebral cages are implanted between the vertebrae.
  • the intervertebral cages may be solid or hollow.
  • the hollow intervertebral cages are generally designed as a casing with two orifices, one on the lower face and one on the upper face; the lateral faces may also be openworked.
  • the surgical treatment generally entails polishing the vertebral plates and employing a bone graft, which is present within the intervertebral cage, when the latter is hollow, and/or around the cage, in order to promote fusion of the vertebrae.
  • these intervertebral cages are often inserted by a posterior approach and that they have a somewhat elongate shape in order to allow them to pass between the roots and the dural sheath.
  • the “height” of a cage is understood as the dimension measured in the direction corresponding to the thickness (or height) of an intervertebral disc.
  • an intervertebral cage for arthrodesis composed of:
  • Aperiodic distribution of the pores is understood as a distribution of the pores according to an aperiodic structure, that is to say according to a structure which is not constructed on the basis of a spatially repeated pattern; such a distribution can also be described as “random” or “stochastic”.
  • the inventors have been able to show that it is possible to improve the compatibility and the relationship of the intervertebral cages with the bone tissue. Stable and long-lasting fusion is thus obtained. There is good colonization of such an intervertebral cage by the bone tissue, in particular with effective penetration of the bone tissue into the part of the upper and/or lower contact zone made of a porous titanium material. The relationship between an intervertebral cage and the bone tissue is thus advantageously improved.
  • the present invention is also directed to an intervertebral cage for arthrodesis comprising the features set out in the following embodiments, which may be combined in all technically conceivable configurations:
  • the intervertebral cages for arthrodesis which are shown in FIGS. 1 and 2 , and are designated as 1 and 2 , respectively, comprise an upper face 10 and a lower face 20 ; each of these faces comprises a respective contact zone, i.e. an upper contact zone 11 and a lower contact zone (not shown), which are intended to contact, respectively, a first vertebra and a second vertebra consecutive to the first vertebra; each of these faces likewise comprises an orifice 15 ; in the cages shown, the upper face 10 has mirror symmetry in relation to the lower face 20 .
  • the two faces, upper and lower, are opposite each other and are generally slightly inclined with respect to each other, for example by an angle of between 0° and 20°; this angle corresponds to the lordosis between the two consecutive vertebrae.
  • These two faces are connected, with continuity of material, by a part 30 .
  • This part 30 comprises in particular a wall which is generally substantially perpendicular to the upper and lower faces. This wall can extend all around the perimeter of the upper and lower faces, as shown in FIG. 1 , or around only part of the perimeter of the upper and lower faces, as shown in FIG. 2 .
  • This part 30 ensures the mechanical rigidity of the intervertebral cage and is configured to resist the forces applied between two consecutive vertebrae.
  • the part 30 is configured to form a cavity 35 intended to receive a bone graft. Said cavity 35 opens out at the orifices of each of the upper and lower faces.
  • Such intervertebral cages are referred to as “monobloc”, and the upper face 10 is not movable with respect to the lower face 20 .
  • the intervertebral cages for arthrodesis in FIGS. 1 and 2 are elongate, and the length L of the upper face (in this case similar to that of the lower face) is equal to or greater than twice their width l; by way of example, this length is between 15 mm and 40 mm, and this width is between 5 mm and 15 mm.
  • the part 30 providing a continuous material connection between the upper face and lower face comprises two longitudinal faces 31 arranged along an axis corresponding to the length, and two lateral faces 32 (for FIG. 1 ) or 34 (for FIG. 2 ) arranged along an axis corresponding to the width.
  • the longitudinal faces 31 comprise thinned zones 33 , for example formed by a lattice structure. These zones can be partially or completely free of material.
  • the intervertebral cages for arthrodesis in FIGS. 1 and 2 have an elongate orifice on the upper face (similar to the one on the lower face), and the length of the orifice is equal to or greater than twice its width; for example, this length is between 10 mm and 25 mm and this width is between 3 mm and 8 mm.
  • the intervertebral cage 1 for arthrodesis in FIG. 1 is substantially parallelepipedal and comprises two parallel longitudinal faces and two parallel lateral faces. These longitudinal and lateral faces are perpendicular to each other and are generally slightly inclined with respect to the normal of the upper face and/or with respect to the normal of the lower face of said cage.
  • One lateral face moreover comprises a cavity 36 ; this cavity is intended to receive an end of a component forming part of a device for gripping the intervertebral cage; such a gripping device allows the surgeon to manipulate the intervertebral cage and then position it between two vertebrae.
  • the cavity arranged on one of the lateral faces is threaded and allows the component forming part of a gripping device to be fixed therein, this component being in the nature of a screw.
  • the intervertebral cage 2 for arthrodesis in FIG. 2 is crescent-shaped and comprises two curved longitudinal faces parallel to each other.
  • the two lateral faces are substantially of semi-cylindrical shape, each the mirror symmetry of the other, and are tangential to the curved lateral faces.
  • These longitudinal and lateral faces are generally slightly inclined with respect to the normal of the upper face and/or with respect to the normal of the lower face of said cage.
  • One lateral face moreover comprises a zone 37 which is intended to cooperate with an end of a component forming part of a device for gripping the intervertebral cage.
  • said zone arranged on one of the lateral faces comprises a cylindrical part situated between the upper face and the lower face of the cage and set back from the perimeters of these faces.
  • This cylindrical part allows the cage to be manipulated with the aid of a gripping device comprising a part in the nature of forceps.
  • the upper and lower contact zones of the upper and lower faces, respectively, of the intervertebral cages shown in FIGS. 1 and 2 are made of a porous titanium material with a thickness of at least 1 mm and with a porosity of between 50% and 90%, where the diameter of the pores (DP) is between 200 ⁇ m and 1 mm, and where the pores have an aperiodic distribution.
  • FIG. 3 shows an image of an example of a porous titanium material of the type in question.
  • This image was taken with an electron scanning microscope, the voltage of the electron beam being regulated at 15 kV.
  • the image is a square, of which the dimension of a side corresponds to a dimension of 3.6 mm.
  • the filaments, interlaced and in part joined together, are made of dense titanium material.
  • the space between these filaments forms a plurality of pores.
  • the filaments have a substantially circular cross section with a diameter DF substantially equal to 200 ⁇ m, and the pores have a diameter DP of substantially between 500 ⁇ m and 700 ⁇ m.
  • the pores have an aperiodic distribution.
  • the porous titanium material is composed of non-alloyed titanium (containing at least 99% by weight of titanium); according to another embodiment, the porous titanium material is composed of alloyed titanium, for example an alloy comprising aluminum and vanadium, known by the nomenclature Ti6Al4V or TA6V. Such materials are biocompatible.
  • the whole of the intervertebral cage is composed of a single titanium material and only the density of this material varies between parts of the intervertebral cage; according to another embodiment, the intervertebral cage is made of one or more biocompatible materials and of the porous titanium material, and the chemical composition of said one or more biocompatible materials differs from that of the porous titanium material.
  • the biocompatible material, different from the porous titanium material is a polymer, for example known by the name PEEK.
  • the intervertebral cage it is possible to form most of the intervertebral cage from said biocompatible material and to add, to an upper face and/or a lower face of the intervertebral cage, at least one part of the contact zone made of a porous titanium material.
  • Such addition can be done by any technique known to a person skilled in the art and making it possible to “attach” a porous titanium material to another material.
  • the porous titanium material is produced by additive manufacturing (also called 3D printing).
  • additive manufacturing is understood as a manufacturing process involving addition of material, in most cases aided by computer. It is defined by the ASTM as being the process of forming an object by addition of material, layer upon layer, as opposed to subtractive processes involving removal of material, such as machining. Such technology is commonly known as 3D printing. Examples that may be mentioned include laser sintering, in particular selective laser sintering (SLS), direct metal laser sintering (DMLS) or e-beam (EBM). “Printers” use a laser which hardens a metal powder at certain locations in order to give form to the final object. Mention may also be made, by way of example, of processes such as electron beam sintering, known in particular as EBM (electron beam melting).
  • EBM electron beam melting

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Cardiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Prostheses (AREA)

Abstract

Disclosed is an intervertebral cage for arthrodesis, where at least part of an upper and/or lower contact zone is made of a porous titanium material with a thickness of at least 1 mm and with a porosity of between 50% and 90%, where the diameter of the pores (DP) is between 200 μm and 1 mm, and where the pores have an aperiodic distribution.

Description

  • The present invention relates to intervertebral cages for arthrodesis, which are also called “intersomatic cages”.
  • Arthrodesis is a surgical operation in which two bones that are initially movable with respect to each other are fixed. It is performed in order to correct a lesion in a bone region and to eliminate the pain associated with movements of this lesion; it is irreversible. It is also referred to as “fusion”.
  • In humans, degeneration of the intervertebral disc tends to reduce the space within the disc and to narrow the foramina through which the nerve roots issue from the spinal canal. This degeneration represents one of the diseases of the spine. The intervertebral discs, it will be remembered, are located in the vertebral column between two consecutive vertebrae. An intervertebral disc comprises a ring of cartilage provided at its center with a gelatinous nucleus. The intervertebral discs are elastic and thus help absorb the shocks to which a vertebral column is subjected.
  • The surgical treatment of degeneration of the intervertebral disc may necessitate arthrodesis (fusion) of one or more vertebral segments in the best possible anatomical position. This technique thus makes it possible to definitively block one or more of the intervertebral articulations of the column. In order to restore the normal space and the anatomical sagittal angle of the segment (lordosis), intervertebral cages are implanted between the vertebrae.
  • The intervertebral cages may be solid or hollow. The hollow intervertebral cages are generally designed as a casing with two orifices, one on the lower face and one on the upper face; the lateral faces may also be openworked.
  • The surgical treatment generally entails polishing the vertebral plates and employing a bone graft, which is present within the intervertebral cage, when the latter is hollow, and/or around the cage, in order to promote fusion of the vertebrae.
  • It will be noted that, in surgery of the lumbar spine, these intervertebral cages are often inserted by a posterior approach and that they have a somewhat elongate shape in order to allow them to pass between the roots and the dural sheath.
  • In the following, the “height” of a cage is understood as the dimension measured in the direction corresponding to the thickness (or height) of an intervertebral disc.
  • Many studies have been carried out with the aim of promoting fusion of the vertebrae by providing means by which it is possible to improve the compatibility and the relationship of the intervertebral cages with the bone tissue; by way of example, mention may be made of the use of reliefs and/or of porosities on the lower and/or upper face, which may be of such a nature as to make fusion easier.
  • Since the compatibility and the relationship of the intervertebral cages with the bone tissue are critical parameters for the quality and durability of the surgical treatment, there is an ever present need to improve the relationship between an intervertebral cage and the bone tissue.
  • To this end, the present invention proposes an intervertebral cage for arthrodesis, composed of:
      • an upper face and a lower face comprising, respectively, an upper contact zone and a lower contact zone which are intended to contact, respectively, a first vertebra and a second vertebra consecutive to the first vertebra, each of these faces comprising an orifice;
      • a part connecting the upper face and the lower face, with continuity of material, and configured to form a cavity intended to receive a bone graft, where said cavity opens out at the orifices of each of the upper and lower faces; where at least part of the upper and/or lower contact zone is made of a porous titanium material with a thickness of at least 1 mm and with a porosity of between 50% and 90%, where the diameter of the pores is between 200 μm and 1 mm, and where the pores have an aperiodic distribution.
  • “Aperiodic distribution of the pores” is understood as a distribution of the pores according to an aperiodic structure, that is to say according to a structure which is not constructed on the basis of a spatially repeated pattern; such a distribution can also be described as “random” or “stochastic”.
  • By virtue of the present invention, the inventors have been able to show that it is possible to improve the compatibility and the relationship of the intervertebral cages with the bone tissue. Stable and long-lasting fusion is thus obtained. There is good colonization of such an intervertebral cage by the bone tissue, in particular with effective penetration of the bone tissue into the part of the upper and/or lower contact zone made of a porous titanium material. The relationship between an intervertebral cage and the bone tissue is thus advantageously improved.
  • The present invention is also directed to an intervertebral cage for arthrodesis comprising the features set out in the following embodiments, which may be combined in all technically conceivable configurations:
      • the porous titanium material is composed of at least 95% by weight of metallic titanium, for example at least 99% by weight of metallic titanium;
      • the porosity of the porous titanium material is between 60% and 80%;
      • the diameter of the pores of the porous titanium material is between 500 μm and 900 μm, for example between 700 μm and 800 μm;
      • the part of the upper and/or lower contact zone made of a porous titanium material occupies a surface area of greater than or equal to 30% of the surface area of the upper and/or lower contact zone, respectively;
      • the porous titanium material is composed of a plurality of filaments of dense titanium material which are interlaced and in part join each other, where the pores are formed by the space between these filaments, and where the filaments are of a substantially circular cross section with a diameter of between 50 and 500 μm, for example between 100 and 300 μm;
      • the part connecting the upper face to the lower face, with continuity of material, comprises an opening suitable for receiving a device for gripping said intervertebral cage;
      • the intervertebral cage is elongate, and in that the length of the upper face and of the lower face is equal to or greater than twice their width, for example with a length of between 15 mm and 40 mm and a width of between 5 mm and 15 mm;
      • the orifice of the upper face and the orifice of the lower face are elongate, and the length of each of the orifices is equal to or greater than twice their width, for example with a length of between 10 mm and 25 mm and a width of between 3 mm and 8 mm;
      • the porous titanium material, with a porosity of between 50% and 90%, where the diameter of the pores is between 200 μm and 1 mm and where the pores have an aperiodic distribution, is produced by additive manufacturing (also called 3D printing);
      • the intervertebral cage is made of a titanium material of substantially constant chemical composition, and the density of the titanium material differs between at least two parts of the cage; according to another embodiment, the intervertebral cage is composed of one or more biocompatible materials and of the porous titanium material, and the chemical composition of said one or more biocompatible materials differs from that of the porous titanium material.
  • Other features and advantages of the present invention will become clear from the following description of non-limiting embodiments which are illustrated in the attached figures, where:
  • FIGS. 1 and 2 are schematic views of two embodiments of intervertebral cages for arthrodesis.
  • FIG. 3 shows an image of an example of porous titanium material constituting at least part of the upper and/or lower contact zone of an intervertebral cage for arthrodesis according to the present invention.
  • The intervertebral cages for arthrodesis which are shown in FIGS. 1 and 2, and are designated as 1 and 2, respectively, comprise an upper face 10 and a lower face 20; each of these faces comprises a respective contact zone, i.e. an upper contact zone 11 and a lower contact zone (not shown), which are intended to contact, respectively, a first vertebra and a second vertebra consecutive to the first vertebra; each of these faces likewise comprises an orifice 15; in the cages shown, the upper face 10 has mirror symmetry in relation to the lower face 20. The two faces, upper and lower, are opposite each other and are generally slightly inclined with respect to each other, for example by an angle of between 0° and 20°; this angle corresponds to the lordosis between the two consecutive vertebrae. These two faces are connected, with continuity of material, by a part 30. This part 30 comprises in particular a wall which is generally substantially perpendicular to the upper and lower faces. This wall can extend all around the perimeter of the upper and lower faces, as shown in FIG. 1, or around only part of the perimeter of the upper and lower faces, as shown in FIG. 2. This part 30 ensures the mechanical rigidity of the intervertebral cage and is configured to resist the forces applied between two consecutive vertebrae. The part 30 is configured to form a cavity 35 intended to receive a bone graft. Said cavity 35 opens out at the orifices of each of the upper and lower faces. Such intervertebral cages are referred to as “monobloc”, and the upper face 10 is not movable with respect to the lower face 20.
  • The intervertebral cages for arthrodesis in FIGS. 1 and 2 are elongate, and the length L of the upper face (in this case similar to that of the lower face) is equal to or greater than twice their width l; by way of example, this length is between 15 mm and 40 mm, and this width is between 5 mm and 15 mm.
  • The part 30 providing a continuous material connection between the upper face and lower face comprises two longitudinal faces 31 arranged along an axis corresponding to the length, and two lateral faces 32 (for FIG. 1) or 34 (for FIG. 2) arranged along an axis corresponding to the width. In the examples shown, the longitudinal faces 31 comprise thinned zones 33, for example formed by a lattice structure. These zones can be partially or completely free of material.
  • The intervertebral cages for arthrodesis in FIGS. 1 and 2 have an elongate orifice on the upper face (similar to the one on the lower face), and the length of the orifice is equal to or greater than twice its width; for example, this length is between 10 mm and 25 mm and this width is between 3 mm and 8 mm.
  • The intervertebral cage 1 for arthrodesis in FIG. 1 is substantially parallelepipedal and comprises two parallel longitudinal faces and two parallel lateral faces. These longitudinal and lateral faces are perpendicular to each other and are generally slightly inclined with respect to the normal of the upper face and/or with respect to the normal of the lower face of said cage. One lateral face moreover comprises a cavity 36; this cavity is intended to receive an end of a component forming part of a device for gripping the intervertebral cage; such a gripping device allows the surgeon to manipulate the intervertebral cage and then position it between two vertebrae. In the present example, the cavity arranged on one of the lateral faces is threaded and allows the component forming part of a gripping device to be fixed therein, this component being in the nature of a screw.
  • The intervertebral cage 2 for arthrodesis in FIG. 2 is crescent-shaped and comprises two curved longitudinal faces parallel to each other. The two lateral faces are substantially of semi-cylindrical shape, each the mirror symmetry of the other, and are tangential to the curved lateral faces. These longitudinal and lateral faces are generally slightly inclined with respect to the normal of the upper face and/or with respect to the normal of the lower face of said cage. One lateral face moreover comprises a zone 37 which is intended to cooperate with an end of a component forming part of a device for gripping the intervertebral cage. In the present example, said zone arranged on one of the lateral faces comprises a cylindrical part situated between the upper face and the lower face of the cage and set back from the perimeters of these faces. This cylindrical part allows the cage to be manipulated with the aid of a gripping device comprising a part in the nature of forceps.
  • In the present examples according to the invention, the upper and lower contact zones of the upper and lower faces, respectively, of the intervertebral cages shown in FIGS. 1 and 2 are made of a porous titanium material with a thickness of at least 1 mm and with a porosity of between 50% and 90%, where the diameter of the pores (DP) is between 200 μm and 1 mm, and where the pores have an aperiodic distribution.
  • FIG. 3 shows an image of an example of a porous titanium material of the type in question. This image was taken with an electron scanning microscope, the voltage of the electron beam being regulated at 15 kV. The image is a square, of which the dimension of a side corresponds to a dimension of 3.6 mm. It clearly shows a continuous material composed of a plurality of filaments 100 that join each other at some places and are separated by an empty space at other places. The material is therefore “branched” according to a three-dimensional structure. The filaments, interlaced and in part joined together, are made of dense titanium material. The space between these filaments forms a plurality of pores. In the example shown, the filaments have a substantially circular cross section with a diameter DF substantially equal to 200 μm, and the pores have a diameter DP of substantially between 500 μm and 700 μm. The pores have an aperiodic distribution.
  • According to one embodiment, the porous titanium material is composed of non-alloyed titanium (containing at least 99% by weight of titanium); according to another embodiment, the porous titanium material is composed of alloyed titanium, for example an alloy comprising aluminum and vanadium, known by the nomenclature Ti6Al4V or TA6V. Such materials are biocompatible.
  • According to one embodiment, the whole of the intervertebral cage is composed of a single titanium material and only the density of this material varies between parts of the intervertebral cage; according to another embodiment, the intervertebral cage is made of one or more biocompatible materials and of the porous titanium material, and the chemical composition of said one or more biocompatible materials differs from that of the porous titanium material. By way of example, the biocompatible material, different from the porous titanium material, is a polymer, for example known by the name PEEK. In such an example, it is possible to form most of the intervertebral cage from said biocompatible material and to add, to an upper face and/or a lower face of the intervertebral cage, at least one part of the contact zone made of a porous titanium material. Such addition can be done by any technique known to a person skilled in the art and making it possible to “attach” a porous titanium material to another material.
  • According to one embodiment, the porous titanium material is produced by additive manufacturing (also called 3D printing). “Additive manufacturing” is understood as a manufacturing process involving addition of material, in most cases aided by computer. It is defined by the ASTM as being the process of forming an object by addition of material, layer upon layer, as opposed to subtractive processes involving removal of material, such as machining. Such technology is commonly known as 3D printing. Examples that may be mentioned include laser sintering, in particular selective laser sintering (SLS), direct metal laser sintering (DMLS) or e-beam (EBM). “Printers” use a laser which hardens a metal powder at certain locations in order to give form to the final object. Mention may also be made, by way of example, of processes such as electron beam sintering, known in particular as EBM (electron beam melting).

Claims (20)

1. An intervertebral cage (1, 2) for arthrodesis, composed of:
an upper face (10) and a lower face (20) comprising, respectively, an upper contact zone (11) and a lower contact zone which are intended to contact, respectively, a first vertebra and a second vertebra consecutive to the first vertebra, each of these faces comprising an orifice (15);
a part (30) connecting the upper face (10) and the lower face (20), with continuity of material, and configured to form a cavity (35) intended to receive a bone graft, where said cavity opens out at the orifices of each of the upper and lower faces;
wherein at least part of the upper and/or lower contact zone is made of a porous titanium material with a thickness of at least 1 mm and with a porosity of between 50% and 90%, where the diameter of the pores (DP) is between 200 μm and 1 mm, and where the pores have an aperiodic distribution.
2. The intervertebral cage as claimed in claim 1, wherein the porous titanium material is composed of at least 95% by weight of metallic titanium, for example at least 99% by weight of metallic titanium.
3. The intervertebral cage as claimed in claim 1, wherein the porosity of the porous titanium material is between 60% and 80%.
4. The intervertebral cage as claimed in claim 1, wherein the diameter of the pores of the porous titanium material is between 500 μm and 900 μm, for example between 700 μm and 800 μm.
5. The intervertebral cage as claimed in claim 1, wherein the part of the upper and/or lower contact zone made of a porous titanium material occupies a surface area of greater than or equal to 30% of the surface area of the upper and/or lower contact zone, respectively.
6. The intervertebral cage as claimed in claim 1, wherein the porous titanium material is composed of a plurality of filaments of dense titanium material which are interlaced and in part join each other, where the pores are formed by the space between these filaments (100), and where the filaments are of a substantially circular cross section with a diameter DF of between 50 and 500 μm, for example between 100 and 300 μm.
7. The intervertebral cage as claimed in claim 1, wherein the part connecting with upper face to the lower face, with continuity of material, comprises an opening (36, 37) suitable for receiving a device for gripping said intervertebral cage.
8. The intervertebral cage as claimed in claim 1, wherein the intervertebral cage is elongate, and wherein that the length of the upper face and of the lower face is equal to or greater than twice their width, for example with a length of between 15 mm and 40 mm and a width of between 5 mm and 15 mm.
9. The intervertebral cage as claimed in claim 8, wherein the orifice of the upper face and the orifice of the lower face are elongate, and in that the length of each of the orifices is equal to or greater than twice their width, for example with a length of between 10 mm and 25 mm and a width of between 3 mm and 8 mm.
10. The intervertebral cage as claimed in claim 1, wherein the porous titanium material, with a porosity of between 50% and 90%, where the diameter of the pores is between 200 μm and 1 mm and where the pores have an aperiodic distribution, is produced by additive manufacturing.
11. The intervertebral cage as claimed in claim 1, wherein the intervertebral cage is made of a titanium material of substantially constant chemical composition, and wherein the density of the titanium material differs between at least two parts of the cage.
12. The intervertebral cage as claimed in claim 1, wherein the intervertebral cage is made of one or more biocompatible materials and of the porous titanium material, and where the chemical composition of said one or more biocompatible materials differs from that of the porous titanium material.
13. The intervertebral cage as claimed in claim 2, wherein the porosity of the porous titanium material is between 60% and 80%.
14. The intervertebral cage as claimed in claim 2, wherein the diameter of the pores of the porous titanium material is between 500 μm and 900 μm, for example between 700 μm and 800 μm.
15. The intervertebral cage as claimed in claim 3, wherein the diameter of the pores of the porous titanium material is between 500 μm and 900 μm, for example between 700 μm and 800 μm.
16. The intervertebral cage as claimed in claim 2, wherein the part of the upper and/or lower contact zone made of a porous titanium material occupies a surface area of greater than or equal to 30% of the surface area of the upper and/or lower contact zone, respectively.
17. The intervertebral cage as claimed in claim 3, wherein the part of the upper and/or lower contact zone made of a porous titanium material occupies a surface area of greater than or equal to 30% of the surface area of the upper and/or lower contact zone, respectively.
18. The intervertebral cage as claimed in claim 4, wherein the part of the upper and/or lower contact zone made of a porous titanium material occupies a surface area of greater than or equal to 30% of the surface area of the upper and/or lower contact zone, respectively.
19. The intervertebral cage as claimed in claim 2, wherein the porous titanium material is composed of a plurality of filaments of dense titanium material which are interlaced and in part join each other, where the pores are formed by the space between these filaments (100), and where the filaments are of a substantially circular cross section with a diameter DF of between 50 and 500 μm, for example between 100 and 300 μm.
20. The intervertebral cage as claimed in claim 3, wherein the porous titanium material is composed of a plurality of filaments of dense titanium material which are interlaced and in part join each other, where the pores are formed by the space between these filaments (100), and where the filaments are of a substantially circular cross section with a diameter DF of between 50 and 500 μm, for example between 100 and 300 μm.
US15/742,919 2015-07-16 2016-07-08 Intervertebral cage for arthrodesis Abandoned US20180368991A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR1556698 2015-07-16
FR1556698A FR3038831B1 (en) 2015-07-16 2015-07-16 INTERVERTEBRAL CAGE FOR ARTHRODESIS
PCT/EP2016/066316 WO2017009242A1 (en) 2015-07-16 2016-07-08 Intervertebral cage for arthrodesis

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2016/066316 A-371-Of-International WO2017009242A1 (en) 2015-07-16 2016-07-08 Intervertebral cage for arthrodesis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US16/816,687 Continuation US11564805B2 (en) 2015-07-16 2020-03-12 Intervertebral cage for arthrodesis

Publications (1)

Publication Number Publication Date
US20180368991A1 true US20180368991A1 (en) 2018-12-27

Family

ID=54329734

Family Applications (2)

Application Number Title Priority Date Filing Date
US15/742,919 Abandoned US20180368991A1 (en) 2015-07-16 2016-07-08 Intervertebral cage for arthrodesis
US16/816,687 Active 2037-05-04 US11564805B2 (en) 2015-07-16 2020-03-12 Intervertebral cage for arthrodesis

Family Applications After (1)

Application Number Title Priority Date Filing Date
US16/816,687 Active 2037-05-04 US11564805B2 (en) 2015-07-16 2020-03-12 Intervertebral cage for arthrodesis

Country Status (5)

Country Link
US (2) US20180368991A1 (en)
EP (1) EP3322386B1 (en)
ES (1) ES2984273T3 (en)
FR (1) FR3038831B1 (en)
WO (1) WO2017009242A1 (en)

Cited By (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111529134A (en) * 2020-04-29 2020-08-14 陕西增材制造研究院有限责任公司 Multi-hole interbody fusion cage and processing method thereof
US10940015B2 (en) 2017-11-21 2021-03-09 Institute for Musculoskeletal Science and Education, Ltd. Implant with improved flow characteristics
US11033394B2 (en) 2016-10-25 2021-06-15 Institute for Musculoskeletal Science and Education, Ltd. Implant with multi-layer bone interfacing lattice
US11051953B2 (en) 2019-07-31 2021-07-06 Zavation Medical Products, Llc Porous spinal implant
US11160668B2 (en) 2017-03-13 2021-11-02 Institute for Musculoskeletal Science and Education, Ltd. Implant with bone contacting elements having helical and undulating planar geometries
US11213405B2 (en) 2017-03-13 2022-01-04 Institute for Musculoskeletal Science and Education, Ltd. Implant with structural members arranged around a ring
US11452611B2 (en) 2016-10-25 2022-09-27 Institute for Musculoskeletal Science and Education, Ltd. Implant with protected fusion zones
WO2023035580A1 (en) * 2021-09-13 2023-03-16 智塑健康科技(嘉兴)有限公司 Fusion cage
US11793652B2 (en) 2017-11-21 2023-10-24 Institute for Musculoskeletal Science and Education, Ltd. Implant with improved bone contact
US11819419B2 (en) 2015-04-29 2023-11-21 Institute for Musculoskeletal Science and Education, Ltd. Implant with curved bone contacting elements
US11826261B2 (en) 2015-04-29 2023-11-28 Institute for Musculoskeletal Science and Education, Ltd. Coiled implants and systems and methods of use thereof
US11857436B1 (en) 2019-07-31 2024-01-02 Zavation Medical Products, Llc Porous spinal implant
US12097123B2 (en) 2015-04-29 2024-09-24 Institute for Musculoskeletal Science and Education, Ltd. Implant with arched bone contacting elements

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018145941A1 (en) * 2017-02-09 2018-08-16 Unilever N.V. A hair conditioning composition
US11185423B2 (en) 2019-01-09 2021-11-30 Osseus Fusion Systems Highly radiographically opaque metal based interbody

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206516A (en) * 1976-12-15 1980-06-10 Ontario Research Foundation Surgical prosthetic device or implant having pure metal porous coating
US4693721A (en) * 1984-10-17 1987-09-15 Paul Ducheyne Porous flexible metal fiber material for surgical implantation
US20050112397A1 (en) * 2003-07-24 2005-05-26 Rolfe Jonathan L. Assembled non-random foams
US20050251257A1 (en) * 2004-05-04 2005-11-10 Mitchell Margaret E Spinal implants with body and insert
US20110190888A1 (en) * 2010-02-01 2011-08-04 Bertele Theodore P Composite Interbody Device And Method of Manufacture
US20120312778A1 (en) * 2005-05-06 2012-12-13 Titan Spine, Llc Processes for producing regular repeating patterns on surfaces of interbody devices
US20140107786A1 (en) * 2012-10-11 2014-04-17 Rhausler, Inc. Fusion cage implant with lattice structure

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5443515A (en) * 1994-01-26 1995-08-22 Implex Corporation Vertebral body prosthetic implant with slidably positionable stabilizing member
GB0119652D0 (en) * 2001-08-11 2001-10-03 Stanmore Implants Worldwide Surgical implant
FR2889442B1 (en) * 2005-08-05 2007-10-05 Ass Pour Les Transferts De Tec METHOD FOR MANUFACTURING AN INTERNAL MEDICAL DEVICE
JP5019346B2 (en) * 2005-12-12 2012-09-05 国立大学法人 岡山大学 Bone-compatible implant and method for producing the same
DE102008044951A1 (en) * 2008-02-05 2009-08-06 Smith & Nephew Orthopaedics Ag Open-pore biocompatible surface layer for an implant, method of manufacture and use
WO2011037668A1 (en) * 2009-09-23 2011-03-31 Zimmer Spine, Inc. Composite implant
BR112012007489A2 (en) * 2009-10-07 2019-09-24 Bio2 Tech Inc porous fabric support structure
WO2013181141A1 (en) * 2012-05-31 2013-12-05 Zimmer, Inc. Anisotropic porous scaffols and method of making anisotropic porous scaffolds
ES2689068T3 (en) * 2012-07-25 2018-11-08 Titan Spine, Inc. Implants that have three different surfaces
DE202013006282U1 (en) * 2013-07-12 2014-04-14 Maxxspine Ltd. Lumbar implant for lumbar spine implantation to restore height in the disc space. (SHARX)

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4206516A (en) * 1976-12-15 1980-06-10 Ontario Research Foundation Surgical prosthetic device or implant having pure metal porous coating
US4693721A (en) * 1984-10-17 1987-09-15 Paul Ducheyne Porous flexible metal fiber material for surgical implantation
US20050112397A1 (en) * 2003-07-24 2005-05-26 Rolfe Jonathan L. Assembled non-random foams
US20050251257A1 (en) * 2004-05-04 2005-11-10 Mitchell Margaret E Spinal implants with body and insert
US20120312778A1 (en) * 2005-05-06 2012-12-13 Titan Spine, Llc Processes for producing regular repeating patterns on surfaces of interbody devices
US20110190888A1 (en) * 2010-02-01 2011-08-04 Bertele Theodore P Composite Interbody Device And Method of Manufacture
US20140107786A1 (en) * 2012-10-11 2014-04-17 Rhausler, Inc. Fusion cage implant with lattice structure

Cited By (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12097123B2 (en) 2015-04-29 2024-09-24 Institute for Musculoskeletal Science and Education, Ltd. Implant with arched bone contacting elements
US11819419B2 (en) 2015-04-29 2023-11-21 Institute for Musculoskeletal Science and Education, Ltd. Implant with curved bone contacting elements
US11826261B2 (en) 2015-04-29 2023-11-28 Institute for Musculoskeletal Science and Education, Ltd. Coiled implants and systems and methods of use thereof
US11033394B2 (en) 2016-10-25 2021-06-15 Institute for Musculoskeletal Science and Education, Ltd. Implant with multi-layer bone interfacing lattice
US11452611B2 (en) 2016-10-25 2022-09-27 Institute for Musculoskeletal Science and Education, Ltd. Implant with protected fusion zones
US12042399B2 (en) 2016-10-25 2024-07-23 Institute for Musculoskeletal Science and Education, Ltd. Implant with protected fusion zones
US11938039B2 (en) 2017-03-13 2024-03-26 Institute for Musculoskeletal Science and Education, Ltd. Implant with structural members arranged around a ring
US11160668B2 (en) 2017-03-13 2021-11-02 Institute for Musculoskeletal Science and Education, Ltd. Implant with bone contacting elements having helical and undulating planar geometries
US11213405B2 (en) 2017-03-13 2022-01-04 Institute for Musculoskeletal Science and Education, Ltd. Implant with structural members arranged around a ring
US10940015B2 (en) 2017-11-21 2021-03-09 Institute for Musculoskeletal Science and Education, Ltd. Implant with improved flow characteristics
US11951018B2 (en) 2017-11-21 2024-04-09 Institute for Musculoskeletal Science and Education, Ltd. Implant with improved flow characteristics
US11793652B2 (en) 2017-11-21 2023-10-24 Institute for Musculoskeletal Science and Education, Ltd. Implant with improved bone contact
US11771566B2 (en) 2019-07-31 2023-10-03 Zavation Medical Products, Llc Porous spinal implant
US11857436B1 (en) 2019-07-31 2024-01-02 Zavation Medical Products, Llc Porous spinal implant
US11051953B2 (en) 2019-07-31 2021-07-06 Zavation Medical Products, Llc Porous spinal implant
CN111529134A (en) * 2020-04-29 2020-08-14 陕西增材制造研究院有限责任公司 Multi-hole interbody fusion cage and processing method thereof
WO2023035580A1 (en) * 2021-09-13 2023-03-16 智塑健康科技(嘉兴)有限公司 Fusion cage

Also Published As

Publication number Publication date
US11564805B2 (en) 2023-01-31
WO2017009242A1 (en) 2017-01-19
EP3322386A1 (en) 2018-05-23
FR3038831A1 (en) 2017-01-20
ES2984273T3 (en) 2024-10-29
EP3322386C0 (en) 2024-07-31
EP3322386B1 (en) 2024-07-31
US20200229945A1 (en) 2020-07-23
FR3038831B1 (en) 2017-07-21

Similar Documents

Publication Publication Date Title
US11564805B2 (en) Intervertebral cage for arthrodesis
US9987051B2 (en) Interbody spacer
US11382763B2 (en) Interbody spacer
US20210361442A1 (en) 3d printed osteogenesis scaffold
US20210186708A1 (en) Intervertebral cage with porosity gradient
US10433979B2 (en) Coiled implants and systems and methods of use thereof
EP3256079B1 (en) Spinal implants with engineered cellular structure and internal imaging markers
US20210338454A1 (en) 3d printed osteogenesis scaffold
EP2772230B1 (en) Fusion prosthesis for the axis
JP2019517372A (en) Implant with independent end plate
AU2016338401B2 (en) Interbody spacer
Sorrentino Struttura reticolare progettata razionalmente per protesi ossee vertebrali trabecolari
WO2021236646A1 (en) 3d printed osteogenesis scaffold

Legal Events

Date Code Title Description
AS Assignment

Owner name: SPINEART SA, SWITZERLAND

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:LEVIEUX, JEROME;REEL/FRAME:045056/0429

Effective date: 20180115

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION